Lina Anderhalten
YOU?
Author Swipe
View article: RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis
RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis Open
Multiple sclerosis (MS) is characterized by a progressive worsening of disability over time. As many regulatory-cleared disease-modifying treatments aiming to slow down this progression are now available, a clear need has arisen for a pers…
View article: A quantitative multi-parameter mapping protocol standardized for clinical research in multiple sclerosis
A quantitative multi-parameter mapping protocol standardized for clinical research in multiple sclerosis Open
Quantitative magnetic resonance imaging (qMRI) involves mapping microstructure in standardized units sensitive to histological properties and supplements conventional MRI, which relies on contrast weighted images where intensities have no …
View article: A quantitative multi-parameter mapping protocol standardized for clinical research in autoimmune neuroinflammatory diseases with white matter abnormalities
A quantitative multi-parameter mapping protocol standardized for clinical research in autoimmune neuroinflammatory diseases with white matter abnormalities Open
Quantitative magnetic resonance imaging (qMRI) involves mapping microstructure in standardized units sensitive to histological properties and supplements conventional MRI, which relies on contrast weighted images where intensities have no …
View article: Emerging MRI and biofluid biomarkers in the diagnosis and prognosis of multiple sclerosis
Emerging MRI and biofluid biomarkers in the diagnosis and prognosis of multiple sclerosis Open
View article: A future of AI-driven personalized care for people with multiple sclerosis
A future of AI-driven personalized care for people with multiple sclerosis Open
Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system resulting in progressive disability accumulation. As there is no cure available yet for MS, the primary therapeutic objective is to reduce rela…
View article: Investigating the Mitoprotective Effects of S1P Receptor Modulators Ex Vivo Using a Novel Semi-Automated Live Imaging Set-Up
Investigating the Mitoprotective Effects of S1P Receptor Modulators Ex Vivo Using a Novel Semi-Automated Live Imaging Set-Up Open
In multiple sclerosis (MS), mitochondrial alterations appear to contribute to disease progression. The sphingosine-1-phosphate receptor modulator siponimod is approved for treating secondary progressive MS. Its preceding compound fingolimo…